126 related articles for article (PubMed ID: 20863084)
1. Synthesis of oligonucleotides carrying amino lipid groups at the 3'-end for RNA interference studies.
Grijalvo S; Ocampo SM; Perales JC; Eritja R
J Org Chem; 2010 Oct; 75(20):6806-13. PubMed ID: 20863084
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of lipid-oligonucleotide conjugates for RNA interference studies.
Grijalvo S; Ocampo SM; Perales JC; Eritja R
Chem Biodivers; 2011 Feb; 8(2):287-99. PubMed ID: 21337501
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and in vitro inhibition properties of siRNA conjugates carrying acridine and quindoline moieties.
Aviñó A; Ocampo SM; Perales JC; Eritja R
Chem Biodivers; 2012 Mar; 9(3):557-66. PubMed ID: 22422523
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and properties of novel L-isonucleoside modified oligonucleotides and siRNAs.
Zhang J; Chen Y; Huang Y; Jin HW; Qiao RP; Xing L; Zhang LR; Yang ZJ; Zhang LH
Org Biomol Chem; 2012 Oct; 10(37):7566-77. PubMed ID: 22895883
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and silencing properties of siRNAs possessing lipophilic groups at their 3'-termini.
Ueno Y; Kawada K; Shibata A; Yoshikawa K; Wataya Y; Kitade Y
Nucleic Acids Symp Ser (Oxf); 2008; (52):503-4. PubMed ID: 18776474
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and silencing properties of siRNAs possessing lipophilic groups at their 3'-termini.
Ueno Y; Kawada K; Naito T; Shibata A; Yoshikawa K; Kim HS; Wataya Y; Kitade Y
Bioorg Med Chem; 2008 Aug; 16(16):7698-704. PubMed ID: 18644731
[TBL] [Abstract][Full Text] [Related]
7. Palmitic acid-conjugated 21-nucleotide siRNA enhances gene-silencing activity.
Kubo T; Yanagihara K; Takei Y; Mihara K; Morita Y; Seyama T
Mol Pharm; 2011 Dec; 8(6):2193-203. PubMed ID: 21985606
[TBL] [Abstract][Full Text] [Related]
8. Stepwise synthesis of oligonucleotide-peptide conjugates containing guanidinium and lipophilic groups in their 3'-termini.
Grijalvo S; Terrazas M; Aviñó A; Eritja R
Bioorg Med Chem Lett; 2010 Apr; 20(7):2144-7. PubMed ID: 20206515
[TBL] [Abstract][Full Text] [Related]
9. Asymmetric RNA duplexes mediate RNA interference in mammalian cells.
Sun X; Rogoff HA; Li CJ
Nat Biotechnol; 2008 Dec; 26(12):1379-82. PubMed ID: 19029911
[TBL] [Abstract][Full Text] [Related]
10. Preparation of Lipid-Conjugated siRNA Oligonucleotides for Enhanced Gene Inhibition in Mammalian Cells.
Grijalvo S; Ocampo SM; Perales JC; Eritja R
Methods Mol Biol; 2021; 2282():119-136. PubMed ID: 33928573
[TBL] [Abstract][Full Text] [Related]
11. Solid-phase synthesis of siRNA oligonucleotides.
Beaucage SL
Curr Opin Drug Discov Devel; 2008 Mar; 11(2):203-16. PubMed ID: 18283608
[TBL] [Abstract][Full Text] [Related]
12. Lipid-conjugated oligonucleotides via "click chemistry" efficiently inhibit hepatitis C virus translation.
Godeau G; Staedel C; Barthélémy P
J Med Chem; 2008 Aug; 51(15):4374-6. PubMed ID: 18605715
[TBL] [Abstract][Full Text] [Related]
13. Influence of assembly of siRNA elements into RNA-induced silencing complex by fork-siRNA duplex carrying nucleotide mismatches at the 3'- or 5'-end of the sense-stranded siRNA element.
Ohnishi Y; Tokunaga K; Hohjoh H
Biochem Biophys Res Commun; 2005 Apr; 329(2):516-21. PubMed ID: 15737617
[TBL] [Abstract][Full Text] [Related]
14. Cationic nucleolipids as efficient siRNA carriers.
Yang HW; Yi JW; Bang EK; Jeon EM; Kim BH
Org Biomol Chem; 2011 Jan; 9(1):291-6. PubMed ID: 21082158
[TBL] [Abstract][Full Text] [Related]
15. The valency of fatty acid conjugates impacts siRNA pharmacokinetics, distribution, and efficacy in vivo.
Biscans A; Coles A; Echeverria D; Khvorova A
J Control Release; 2019 May; 302():116-125. PubMed ID: 30940496
[TBL] [Abstract][Full Text] [Related]
16. Interaction of cholesterol-conjugated ionizable amino lipids with biomembranes: lipid polymorphism, structure-activity relationship, and implications for siRNA delivery.
Zhang J; Fan H; Levorse DA; Crocker LS
Langmuir; 2011 Aug; 27(15):9473-83. PubMed ID: 21648950
[TBL] [Abstract][Full Text] [Related]
17. Improving RNA interference in mammalian cells by 4'-thio-modified small interfering RNA (siRNA): effect on siRNA activity and nuclease stability when used in combination with 2'-O-alkyl modifications.
Dande P; Prakash TP; Sioufi N; Gaus H; Jarres R; Berdeja A; Swayze EE; Griffey RH; Bhat B
J Med Chem; 2006 Mar; 49(5):1624-34. PubMed ID: 16509579
[TBL] [Abstract][Full Text] [Related]
18. Gene silencing activity of siRNAs with a ribo-difluorotoluyl nucleotide.
Xia J; Noronha A; Toudjarska I; Li F; Akinc A; Braich R; Frank-Kamenetsky M; Rajeev KG; Egli M; Manoharan M
ACS Chem Biol; 2006 Apr; 1(3):176-83. PubMed ID: 17163665
[TBL] [Abstract][Full Text] [Related]
19. Fully 2'-modified oligonucleotide duplexes with improved in vitro potency and stability compared to unmodified small interfering RNA.
Allerson CR; Sioufi N; Jarres R; Prakash TP; Naik N; Berdeja A; Wanders L; Griffey RH; Swayze EE; Bhat B
J Med Chem; 2005 Feb; 48(4):901-4. PubMed ID: 15715458
[TBL] [Abstract][Full Text] [Related]
20. Effect of siRNA nuclease stability on the in vitro and in vivo kinetics of siRNA-mediated gene silencing.
Bartlett DW; Davis ME
Biotechnol Bioeng; 2007 Jul; 97(4):909-21. PubMed ID: 17154307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
